Should plain 1% lidocaine or lidocaine with epinephrine be used for local anesthesia during a loop electrosurgical excision procedure (LEEP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lidocaine with Epinephrine Should Be Used for LEEP

Use lidocaine with epinephrine (1:100,000) for local anesthesia during LEEP procedures. The addition of epinephrine provides superior hemostatic control and significantly reduces delayed hemorrhage without increasing adverse outcomes.

Evidence-Based Rationale

Hemostatic Benefits of Epinephrine

The most compelling evidence comes from a 2017 study demonstrating that local anesthesia with lidocaine plus epinephrine (1:100,000) significantly reduced delayed hemorrhage compared to procedures performed without epinephrine (P=0.001) 1. Among 369 LEEP patients, those receiving lidocaine with epinephrine had substantially lower rates of post-procedure bleeding requiring intervention (electrocauterization, packing, or hemostatic agents) between days 1-30 post-procedure 1.

This hemostatic advantage directly impacts patient morbidity by:

  • Reducing emergency department visits for delayed bleeding
  • Decreasing need for secondary interventions
  • Minimizing blood loss and associated complications

Safety Profile on Cervical Tissue

The cervix is not an end-artery territory, making epinephrine safe for use in this anatomic location. Dermatologic surgery guidelines provide strong evidence (Level A, Grade I-II) that epinephrine is safe for use in areas historically considered "at risk," including digits, nose, and ears 2. Multiple systematic reviews found no cases of tissue necrosis with epinephrine use in these locations 2.

The cervix has robust collateral blood supply, making concerns about vasoconstrictor-induced ischemia unfounded in this context.

Dosing Recommendations

For LEEP procedures, use:

  • 2% lidocaine with 1:100,000 epinephrine
  • Maximum dose: 7 mg/kg (with epinephrine) 2
  • Typical volume: 10 mL for paracervical block 3

The FDA label confirms that when larger volumes are required, solutions containing epinephrine should be used except when vasopressors are contraindicated 4.

Pain Control Efficacy

A 2018 randomized trial comparing paracervical block with lidocaine-epinephrine versus lidocaine spray found that the paracervical block with epinephrine provided effective anesthesia with mean pain scores of 4.2 during excision 3. While both methods were within non-clinically significant margins, the epinephrine-containing solution had the added benefit of hemostasis.

Adverse Event Profile

The epinephrine formulation has a favorable safety profile. In the 2018 trial, adverse events (tinnitus, numbness, palpitation, tachycardia, hypertension) occurred in only 8 cases with paracervical block, which is acceptable given the hemostatic benefits 3. These minor systemic effects are transient and manageable.

Clinical Algorithm

Standard approach:

  1. Use 2% lidocaine with 1:100,000 epinephrine
  2. Administer as paracervical block (10 mL total)
  3. Wait 5-10 minutes for optimal vasoconstriction
  4. Proceed with LEEP

Contraindications to epinephrine (use plain lidocaine only):

  • Uncontrolled hypertension
  • Severe cardiac arrhythmias
  • Concurrent MAOI or tricyclic antidepressant use 4
  • Known hypersensitivity to epinephrine

For patients with stable cardiac disease: Epinephrine is safe in small amounts (Level B, Grade I-II evidence) 2.

Important Caveats

  • Aspirate before injection to avoid intravascular administration 2
  • Use incremental injections to monitor for early toxicity 2
  • Consider buffering with sodium bicarbonate (1:9 or 1:10 ratio) to reduce injection pain (Level A, Grade I-II evidence) 2
  • Monitor for signs of local anesthetic systemic toxicity (circumoral numbness, tinnitus, metallic taste) 2

The evidence clearly favors lidocaine with epinephrine for LEEP procedures based on superior hemorrhage prevention, established safety profile, and adequate anesthetic efficacy. Plain lidocaine should be reserved only for specific contraindications to epinephrine.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.